Medfinder
Back to blog

Updated: January 28, 2026

How to Help Your Patients Save Money on Durezol: A Provider's Guide to Savings Programs

Author

Peter Daggett

Peter Daggett

Provider reviewing savings chart with medication and patient assistance card

A provider guide to helping ophthalmology and optometry patients afford Durezol (difluprednate) in 2026: PAPs, discount cards, prior auth strategies, and more.

Durezol (difluprednate 0.05%) is essential for many patients recovering from eye surgery or managing uveitis — but the cost can be a real barrier. Brand-name Durezol retails for $250–$400 per bottle, and even with the ongoing shortage forcing some patients to the brand when generic is unavailable, cost concerns are rising.

As a prescriber, you have more tools at your disposal than you may realize. This guide covers every savings option available for your patients in 2026, with practical guidance on how to apply each one.

Understanding the Cost Landscape

Before recommending specific savings programs, it helps to understand the pricing landscape your patients are navigating:

Brand Durezol (cash price): $250–$400 per 5 mL bottle

Generic difluprednate (retail): ~$303 average

Generic with GoodRx/SingleCare: $44–$49 when available

With insurance (generic Tier 1–2): $10–$50 copay

With insurance (brand Tier 3): $50–$100+ copay

During the current shortage, patients who would normally fill generic at $44–$49 may be forced to fill brand Durezol at much higher cost. This is where proactive provider support makes a real difference.

1. Novartis Patient Assistance Foundation (NPAF)

The Novartis Patient Assistance Foundation provides brand-name Durezol at no cost to qualifying patients. This is the most valuable option for uninsured or underinsured patients.

Program details:

Eligibility is based on income and insurance status

Requires prescriber information and signature

Apply at the Novartis Patient Assistance Foundation website or by phone

Medication is delivered to the patient's home or the prescriber's office

Action step for your practice: Have your intake or checkout staff routinely screen post-surgical and uveitis patients for insurance status and financial need, and keep NPAF application materials readily available.

2. Prescription Discount Cards: GoodRx and SingleCare

For patients who have insurance but face high copays on Tier 3 brand Durezol, or who need to pay cash for the generic when their insurance doesn't cover it, discount cards offer a valuable alternative.

GoodRx: Brings generic difluprednate to $44–$49 per 5 mL bottle at many pharmacies. The GoodRx website shows prices at specific nearby pharmacies, helping patients identify the cheapest location.

SingleCare: Offers comparable savings (~$46 per bottle at participating pharmacies). Some patients find SingleCare prices slightly better at specific chains.

Action step: Print or email patients a direct GoodRx link for difluprednate as part of your post-surgical discharge instructions. Even a few seconds of proactive guidance can save patients hundreds of dollars.

3. Prior Authorization Strategies for Durezol Coverage

When patients face insurance barriers to Durezol coverage, prior authorization (PA) is often the solution. Common scenarios:

Step therapy requirement: Some plans require patients to fail on prednisolone acetate before approving difluprednate. In your PA request, document clinical rationale clearly — e.g., complexity of the surgery, severity of inflammation, or prior steroid-related IOP elevation with prednisolone.

Brand coverage during generic shortage: Document the ongoing ASHP shortage in your PA request. Reference the shortage date (April 2024) and the ASHP listing. Many insurers will approve brand coverage at the generic tier when generic unavailability is documented.

Formulary exceptions: If Durezol is not on formulary at all, a formulary exception request with clinical documentation (non-inferiority to alternatives is well-supported in the literature) often succeeds.

4. Directing Patients to Generic Difluprednate When Available

When the generic is available, it is therapeutically equivalent to brand Durezol. In most states, pharmacists can substitute a generic automatically unless you specify "brand only" on the prescription. Unless there is a clinical reason to specify brand (very rare for Durezol), write prescriptions for difluprednate ophthalmic emulsion 0.05% generically — this gives the pharmacist and patient the most flexibility to find affordable supply.

5. Using medfinder to Help Patients Find Affordable Stock

Directing patients to medfinder for providers reduces callbacks to your practice while giving patients a practical tool to find Durezol in stock. medfinder contacts pharmacies on behalf of patients to find which ones have it available — helping patients find the generic when it is in stock, which keeps their cost as low as possible.

6. Building a Practice Savings Protocol

Consider incorporating a standardized savings conversation into your post-surgical discharge protocol:

Screen patients for insurance status before or at the time of prescribing

Provide GoodRx/SingleCare savings card info with all Durezol prescriptions

Flag uninsured/underinsured patients for NPAF application assistance

Write Durezol prescriptions as generic (difluprednate 0.05%) unless there's a specific clinical reason for brand

Keep a list of local pharmacies with consistent generic difluprednate supply for quick referral

For guidance on helping patients find Durezol in stock during the shortage, see our provider guide to finding Durezol in stock.

Frequently Asked Questions

The Novartis Patient Assistance Foundation (NPAF) provides brand-name Durezol at no cost to qualifying uninsured or underinsured patients who meet income requirements. Apply through the NPAF website or phone line. Prescriber information and signature are required. This is the most valuable option for patients who cannot afford Durezol.

Document clinical necessity clearly in the PA request: severity of post-surgical inflammation, complexity of the surgery, or failure or contraindication of alternatives. For brand coverage during the generic shortage, reference the April 2024 ASHP drug shortage listing. Most plans will approve coverage with adequate clinical documentation.

In almost all cases, write the prescription generically (difluprednate ophthalmic emulsion 0.05%) unless there is a specific clinical reason for brand. Writing generically gives pharmacists and patients the flexibility to fill with the most affordable available option. Most insurers also reimburse generic at a lower tier.

GoodRx and SingleCare both offer strong savings on generic difluprednate when available — bringing the price to $44–$49 per 5 mL bottle, compared to ~$303 at retail. Advise patients to compare prices at specific nearby pharmacies on GoodRx.com, as prices vary by location and the medication must be in stock.

medfinder helps by finding which pharmacies near your patient have generic difluprednate in stock. The generic with a GoodRx coupon costs $44–$49, compared to $250–$400 for brand Durezol out of pocket. By locating available generic stock, medfinder helps patients avoid being forced to pay brand prices during the shortage.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Durezol also looked for:

31,889 have already found their meds with Medfinder.

Start your search today.

31K+
5-star ratingTrusted by 31,889 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?